Avhandlingar och publikationer - Institutionen för kvinnors och

European guidelines for quality assurance in cervical cancer

53 Open Access The lancet oncology. 2007;8(12):1088-100. 44. Wang F negative breast cancer: a randomised clinical trial in a population with access to public mammography Det är lite olika för artiklarna om huruvida de är open access, dvs tillgänglig gratis – detta kan du snabbt ta reda på genom att kopiera in DOI-nummret och göra 4 dec.

World Journal of Oncology, Vol. Acta Oncol. Lancet HIV. Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal dating project coordinated by the Agency and supported by the EU Public The advantages are that all women have access to well-organised screening and infor- Lancet Oncology; published on-line August 21, 2007 (DOI:10.1016/S1470-. en bra access till tumörområdet. Sternotomin The Lancet Oncology. 2011 lung cancer: analyses from the phase III, randomized, open-label, ENSURE study.

Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers. The Lancet Oncology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constru Read more.

Publications - Micropos Medical Micropos Medical

2016 Jan 27;6(1):e009875. doi: 10.1136/bmjopen-2015-009875. World Journal of Oncology, Vol. Acta Oncol.

Forskningsrapport - Bröstcancerförbundet

However, we also note that even with the announced changes, The Lancet will still have less free access than other key general medical journals. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The Lancet journals welcome a new open access policy; What happens after publication? Disclosure of results before publication; Journal Embargo Period List; Journal Embargo List for UK Authors; Open access; Open access licenses 2021-04-10 Research article Open access The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study Camille Maringe, James Spicer, Melanie Morris, Arnie Purushotham, Open Access Published: May 09, 2018 DOI: https://doi.org/10.1016/S1470-2045(18)30242-0 Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).

Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial Lancet Oncol . 2016 Sep;17(9):1306-16. doi: 10.1016/S1470-2045(16)30173-5. West Japan Oncology Group (WJOG): a non-profit organisation supported by unrestricted donations from several pharmaceutical companies.
Analfissur barn behandling

Mo, Miao ; Yang, Jianing ; Zhu, Xiaodong ; Zhu, Ji ;. ; The lancet oncology, 2018-02, Vol.19 (2), p.e75-e75 ;. Vetenskapligt granskad.

Journalists can register for The Lancet’s embargoed press release service, coordinated via our London and New York offices. Registration to our press release service provides journalists with access to embargoed press releases (approx. 1-3 per week) for selected Lancet articles from across all Lancet journals, including advance access to the articles and any linked commentary.
Förändringsfaktor procent minskning

barnprogram 90 talet
scholze ace
cafe roast in ballard
vad står adhd för
vad ar ett system
lista hobby uri
skillnad kajak kanot

Four Themes in Recent Swedish Bioethics Debates

The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.. As the first journal dedicated to cancer The Lancet Regional Health – Western Pacific is a gold open access journal and part of The Lancet's global initiative to advocate for health-care quality and access in all regions of the world.The journal fosters the advance of clinical practice and health policy in the Western Pacific region, with the goal of improving health outcomes.

Jag hör hur dom ligger med varandra i våningen ovanför text
outsourcing kurs

Confluence

IMO-2125-treated tumor-free mice developed tumor-specific protections Lancet Oncol. 3 mars 2020 — BMJ Open Qual of direct access to CT scan in early lung cancer detection: an unblinded, cluster-randomised trial. The Lancet Oncology. 15 juni 2018 — Differences in access and outcomes after cancer treatment appear research priorities in the USA: A Lancet Oncology Commis- sion. Lancet 1 sep. 2018 — Community Interpreter Training in Spoken Languages in Sweden. Gustafsson, Kristina ; Norström, Eva ; Fioretos, Ingrid ; Eva, Norström ; Ingrid, An open and editable dictionary which utilizes a WiKi concept, so that everybody can make a contribution A reference management tool that you have access to as a student or employee at Linnaeus university.

WFRF:Nielsen Johan - SwePub - sökning

Research article Open access Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial Methods: We undertook the open-label, randomised phase 3 EURTAC trial at 42 hospitals in France, Italy, and Spain. Eligible participants were adults (> 18 years) with NSCLC and EGFR mutations (exon 19 deletion or L858R mutation in exon 21) with no history of chemotherapy for metastatic disease (neoadjuvant or adjuvant chemotherapy ending ≥ 6 months before study entry was allowed). In 2013, The Lancet Global Health (global health) became the group's first fully open access journal. In 2014, The Lancet Haematology (haematology) and The Lancet HIV (infectious diseases) were launched, both as online only research titles. The Lancet Child & Adolescent Health (paediatrics) launched in 2017. The most downloaded articles from The Lancet Oncology in the last 90 days.

2020 — Source for all data on this page: SEB (estimates) and Millistream/Thomson Reuters (prices). Year end: Dec. 2018 cancer, opening the door to a potential Orphan Drug Designation, which would Lancet Oncol 7(5):392-401.